An influential thought leader, nurse advocate and international speaker on the future of nursing and emerging innovations impacting nursing practice and patient care. Using disruption and the non-acceptance of the status quo in the relentless pursuit of nurse-led innovation. A Robert Wood Johnson Foundation Executive Nurse Fellow alumna and ASU/AONE Executive Fellow in Innovative Health Leadership alumna.
The first Vice President of Innovation at the American Nurses Association, created the innovation framework, including the ANA Innovation Awards, Innovation Lab, NursePitch, Podcast, NurseJam and strategic partnerships. Former chief nurse executive with 20 years of deep expertise in shared governance, building cultures of innovation and improving the patient experience.
Current chief clinical officer, incorporating gratitude and compassion in the form of patient/family recognition to decrease clinician burnout, increase employee engagement and improve the patient experience.
Author of the Amazon International Best Seller, The Nurse's Guide to Innovation; The Innovation Roadmap: A Guide for Nurse Leaders; Artificial Intelligence and Robotics: The Nurse Leader's Primer and The Nurse Manager’s Guide to an Intergenerational Workforce.
Gregory has over 25 years of private equity investment and business development experience. He has served on 20 boards of directors: 17 private and 3 publicly traded companies.
He currently serves on the Columbia University Department of Ophthalmology Board of Advisors.
Gregory is involved in a broad range of fields including medical technology, pharma and tech fields. He has provided guidance on issues associated with fund raising, business strategy, corporate expansion, corporate combinations and organizational development.
He has been involved with 7 IPOs and 5 mergers. He has helped to introduce over 100 new company/pharma product/drug delivery candidates to off-shore clients.
Mr. Zaic has managed 7 venture capital funds totaling over $150 million as a general partner. During his career, he has led portfolio company investments from seed stage to Initial Public Offering.
During his investment career, more than 90% of his realized portfolio company investments have achieved an IPO or a successful merger. His investment track record (1986-present) is an IRR of 31% per year.
Other notable engagements:
ILife Science and Healthcare Venture Summit (Boston, 2009)
N3 East Investment in Innovation (Boston, 2012, 2011 and 2010)
Crossroads of Ideas and Capital: Vision 2015 (New Haven, 2011)